Published in J Lipid Res on May 21, 2009
Cholesterol: its regulation and role in central nervous system disorders. Cholesterol (2012) 1.08
Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type Specific Gene and Protein Expression in the Central Nervous System. PLoS One (2016) 0.76
Cholesterol impairment contributes to neuroserpin aggregation. Sci Rep (2017) 0.75
Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production. Front Pharmacol (2017) 0.75
Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach. J Mol Neurosci (2017) 0.75
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol (2000) 8.07
CNS synaptogenesis promoted by glia-derived cholesterol. Science (2001) 6.04
Statins and the risk of dementia. Lancet (2000) 5.65
Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron (1999) 3.70
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem (1987) 3.04
Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A (1986) 2.80
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest (1989) 2.71
Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest (1997) 2.44
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem (2004) 2.19
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol (2002) 2.18
Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A (1979) 1.96
Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy (2003) 1.93
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids (1991) 1.90
Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem (2004) 1.82
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol (2002) 1.79
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest (1991) 1.64
Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma (2008) 1.62
HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol (2003) 1.57
The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol A Biol Sci Med Sci (2002) 1.32
ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol Dis (2005) 1.30
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci (2008) 1.28
Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J (2001) 1.27
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol (2007) 1.26
Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res (1992) 1.25
Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease. J Neurochem (2008) 1.24
Association between statin use and Alzheimer's disease. Neuroepidemiology (2004) 1.23
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett (1995) 1.14
Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy (2003) 1.11
Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res (2005) 1.09
Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem (1994) 1.07
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurol (2003) 1.07
Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim Biophys Acta (1996) 1.06
Apolipoprotein E and the response of the brain to injury. Acta Neurochir Suppl (1999) 1.06
Lipid compositions of different regions of the human brain during aging. J Neurochem (1990) 1.06
Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. J Alzheimers Dis (2006) 1.05
Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology (2002) 1.04
Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol (2002) 1.02
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease. J Neurosci (2008) 1.02
Simvastatin-associated memory loss. Pharmacotherapy (2001) 1.01
Statins of different brain penetrability differentially affect CSF PLTP activity. Dement Geriatr Cogn Disord (2006) 1.00
Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis. Mol Pharmacol (2008) 0.97
Membrane lipids in the aging human brain. J Neurochem (1991) 0.93
Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol. Glia (2001) 0.93
An in vitro study of the effects of lovastatin on human fetal brain cells. Neurotoxicol Teratol (1995) 0.87
Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide. Int J Neuropsychopharmacol (2001) 0.87
Effects of apoE on neuronal signaling and APP processing in rodent brain. Brain Res (2006) 0.85
The association of apolipoprotein E polymorphism with memory: a population based study. Neurosci Lett (1995) 0.84
Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation. J Neurosci Res (2008) 0.83
Cholesterol deficiency perturbs actin signaling and glutamate homeostasis in hippocampal astrocytes. Brain Res (2006) 0.82
A clinical focus on statins. Curr Opin Investig Drugs (2001) 0.79
Investigating the potential neuroprotective effects of statins on DNA damage in mouse striatum. Food Chem Toxicol (2008) 0.79
Statin use and hippocampal volumes in elderly subjects at risk for Alzheimer's disease: a pilot observational study. Am J Alzheimers Dis Other Demen (2004) 0.78
Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statins. Dement Geriatr Cogn Disord (2004) 0.76
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest (2007) 5.38
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis (2006) 1.82
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem (2003) 1.74
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis (2008) 1.40
Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem (2003) 1.31
Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim Biophys Acta (2005) 1.02
Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. Biochim Biophys Acta (2011) 1.01
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study. J Lipid Res (2011) 1.00
Statins of different brain penetrability differentially affect CSF PLTP activity. Dement Geriatr Cogn Disord (2006) 1.00
Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation (2003) 0.98
Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins. J Lipid Res (2006) 0.98
An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. J Biol Chem (2008) 0.97
Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation. Biochemistry (2010) 0.96
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). Am J Cardiol (2004) 0.95
Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology. Biochim Biophys Acta (2008) 0.95
Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. J Neurosci Res (2005) 0.93
Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. J Lipid Res (2003) 0.93
Linkage and association of phospholipid transfer protein activity to LASS4. J Lipid Res (2011) 0.91
Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement. J Lipid Res (2002) 0.90
PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity. J Lipid Res (2003) 0.87
Genetic and nongenetic sources of variation in phospholipid transfer protein activity. J Lipid Res (2009) 0.87
Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity. Biochim Biophys Acta (2002) 0.86
Phospholipid transfer protein reduces phosphorylation of tau in human neuronal cells. J Neurosci Res (2009) 0.85
Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice. Physiol Genomics (2002) 0.85
PLTP is present in the nucleus, and its nuclear export is CRM1-dependent. Biochim Biophys Acta (2009) 0.84
Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus of Alzheimer's disease brains. J Histochem Cytochem (2013) 0.83
Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. J Lipid Res (2002) 0.83
Quantitative trait locus mapping of genes that regulate phospholipid transfer activity in SM/J and NZB/BlNJ inbred mice. Arterioscler Thromb Vasc Biol (2003) 0.82
Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. J Alzheimers Dis (2008) 0.80
Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity. Biochim Biophys Acta (2011) 0.79
Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein. Biochim Biophys Acta (2011) 0.78
Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients. Clin Chim Acta (2010) 0.77
Readers' responses to the webcast video editorial entitled "evidence-based medicine or faith-based medicine?". MedGenMed (2005) 0.75
Unobserved Heterogeneity in Response to Treatment for Depression Through Videoconference. Psychiatr Rehabil J (2017) 0.75
Low-density lipoprotein inhibits secretion of phospholipid transfer protein in human trophoblastic BeWo cells. Exp Biol Med (Maywood) (2004) 0.75